Original Articles
31 July 2025
Early Access
The effect of type 2 diabetes mellitus on clinical symptoms, sputum molecular test results, and lesions in thoracic photos of pulmonary tuberculosis patients
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
116
Views
36
Downloads
Authors
Pulmonary tuberculosis (TB) remains a major global health issue, particularly in developing countries. Type 2 diabetes mellitus (T2DM) has been linked to increased susceptibility and more severe TB presentations, though evidence on its impact remains inconsistent. This prospective cohort study, conducted at RSUP Dr. Wahidin Sudirohusodo Makassar from August to November 2024, evaluated 90 bacteriologically confirmed pulmonary TB patients, with and without T2DM. Clinical symptoms, sputum molecular test (RMT) results, and radiographic lesion extent were assessed. TB patients with T2DM showed significantly more severe symptoms (p=0.002), more extensive lung lesions (p=0.008), and a lower rate of RMT positivity (p=0.033). These findings suggest that T2DM is associated with more severe disease manifestations and broader lung involvement but reduced molecular test positivity in pulmonary TB patients.
Altmetrics
Downloads
Download data is not yet available.
Citations
WHO. Global tuberculosis report 2024. Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024. Accessed: 26/04/2025.
Tong X, Wang D, Wang H, et al. Clinical features in pulmonary tuberculosis patients combined with diabetes mellitus in China: an observational study. Clin Respir J 2021;15:1012-8. DOI: https://doi.org/10.1111/crj.13405
PAHO/WHO. Tuberculosis resurges as top infectious disease killer. Available from: https://www.paho.org/en/news/1-11-2024-tuberculosis-resurges-top-infectious-disease-killer. Accessed on: 26/04/2025.
Kemenkes RI. Repository - Aplikasi Repository Kementrian Kesehatan Republik Indonesia. Available from: https://repository.kemkes.go.id/book/124. Accessed on: 25/04/2025.
Lee PH, Fu H, Lee MR, et al. Tuberculosis and diabetes in low and moderate tuberculosis incidence countries. Int J Tuberc Lung Dis 2018;22:7-16. DOI: https://doi.org/10.5588/ijtld.17.0329
Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One 2012;7:e46502. DOI: https://doi.org/10.1371/journal.pone.0046502
Lee PH, Lin HC, Huang ASE, et al. Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PLoS One 2014;9:e92623. DOI: https://doi.org/10.1371/journal.pone.0092623
Banurekha V, Bhatnagar T, Savithri S, et al. Sputum conversion and treatment success among tuberculosis patients with diabetes treated under the Tuberculosis Control Programme in an Urban setting in South India. Indian J Community Med 2017;42:180-2. DOI: https://doi.org/10.4103/ijcm.IJCM_179_16
Shariff NM, Safian N. Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: a case control study. Int J Mycobacteriol 2015;4:323-9. DOI: https://doi.org/10.1016/j.ijmyco.2015.09.003
Wikurendra EA, Nurika G, Tarigan YG, Kurnianto AA. Risk factors of pulmonary tuberculosis and countermeasures: a literature review. Open Access Maced J Med Sci 2021;9:549-55. DOI: https://doi.org/10.3889/oamjms.2021.7287
Caetano Mota P, Carvalho A, Valente I, et al. Preditores de conversão tardia dos exames micobacteriológicos direto e cultural de expetoração numa população portuguesa com tuberculose pulmonary. Rev Port Pneumol 2012;18:72-9. [Article in Portuguese]. DOI: https://doi.org/10.1016/j.rppneu.2011.12.005
Babalik A, Kiziltas S, Arda H, et al. Factors affecting smear conversion in tuberculosis management. Med Sci Int Med J 2012;1:351. DOI: https://doi.org/10.5455/medscience.2012.01.8036
Liang CP, Han S, Senokuchi T, Tall AR. The macrophage at the crossroads of insulin resistance and atherosclerosis. Circ Res 2007;100:1546-55. DOI: https://doi.org/10.1161/CIRCRESAHA.107.152165
Huang LK, Wang HH, Lai YC, Chang SC. The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients. PLoS One 2017;12:e0179750. DOI: https://doi.org/10.1371/journal.pone.0179750
Buasroung P, Petnak T, Liwtanakitpipat P, Kiertiburanakul S. Prevalence of diabetes mellitus in patients with tuberculosis: a prospective cohort study. Int J Infect Dis 2022;116:374-9. DOI: https://doi.org/10.1016/j.ijid.2022.01.047
Santos A, Magro DO, Evangelista-Poderoso R, Saad MJA. Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications. Diabetol Metab Syndr 2021;13:23. DOI: https://doi.org/10.1186/s13098-021-00639-2
van der Zalm MM, Jongen VW, Swanepoel R, et al. Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completion. EClinicalMedicine 2024;67:102406. DOI: https://doi.org/10.1016/j.eclinm.2023.102406
Katalinić-Janković V, Furci L, Cirillo DM. Microbiology of mycobacterium tuberculosis and a new diagnostic test for TB. Eur Respir Monogr 2012;58:8-13. DOI: https://doi.org/10.1183/1025448x.10022311
Peng YF. Pulmonary tuberculosis and diabetes mellitus: epidemiology, pathogenesis and therapeutic management (review). Med Int 2023;4:4. DOI: https://doi.org/10.3892/mi.2023.128
Zhan S, Juan X, Ren T, et al. Extensive radiological manifestation in patients with diabetes and pulmonary tuberculosis: a cross-sectional study. Ther Clin Risk Manag 2022;18:595-602. DOI: https://doi.org/10.2147/TCRM.S363328
Fadillah NA, Sulistiana R, Handayani F. Comparison of chest X-ray of pulmonary TB patients with DM and non DM at Anutapura Palu Hospital in 2020. J EduHealth 2023;14:433-40.
Eun Yoo J, Kim D, Han K, et al. Diabetes status and association with risk of tuberculosis among Korean adults. JAMA Netw Open 2021;4:e2126099. DOI: https://doi.org/10.1001/jamanetworkopen.2021.26099
Visca D, Pignatti P, Spanevello A, et al. Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects. Pharmacol Res 2018;137:230-5. DOI: https://doi.org/10.1016/j.phrs.2018.10.008
Babak BSL, Gorbunova GMV, Gubernatorova GEE, Malyavin MAG. Association between diabetes mellitus and lower respiratory tract and pulmonary diseases: scientific discussion. Therapy 2024;5:135-43. DOI: https://doi.org/10.18565/therapy.2024.5.135-143
Gil-Santana L, Almeida JL, Oliveira CAM, et al. Diabetes is associated with worse clinical presentation in tuberculosis patients from Brazil: a retrospective cohort study. PLoS One 2016;11:e0146876. DOI: https://doi.org/10.1371/journal.pone.0146876
Chang JT, Dou HY, Yen CL, et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc 2011;110:372-81. DOI: https://doi.org/10.1016/S0929-6646(11)60055-7
Nair A, Greeny A, Nandan A, et al. Advanced drug delivery and therapeutic strategies for tuberculosis treatment. J Nanobiotechnology 2023;21:414. DOI: https://doi.org/10.1186/s12951-023-02156-y
Maison DP. Tuberculosis pathophysiology and anti-VEGF intervention. J Clin Tuberc Other Mycobact Dis 2022;27:100300. DOI: https://doi.org/10.1016/j.jctube.2022.100300
Silva DR, Muñoz-Torrico M, Duarte R, et al. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol 2018;44:145-52. DOI: https://doi.org/10.1590/s1806-37562017000000443
Shebani A, Hnish M, Elmelliti H, Lutfe Abdussalam A. Massive hemoptysis in pulmonary tuberculosis from rasmussen pseudoaneurysm. Cureus 2022;14:e30117. DOI: https://doi.org/10.7759/cureus.30117
Zhang L, Jiang F, Xie Y, et al. Diabetic endothelial microangiopathy and pulmonary dysfunction. Front Endocrinol 2023;14:1073878. DOI: https://doi.org/10.3389/fendo.2023.1073878
Sulistiana R. Correlation between chest X-Rays and TCM (rapid molecular tests) in pulmonary tuberculosis patients at Anutapura Hospital Palu. J EduHealth 2023;14:581-5.
Ferlita S, Yegiazaryan A, Noori N, et al. Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially mycobacterium tuberculosis. J Clin Med 2019;8:2219. DOI: https://doi.org/10.3390/jcm8122219
Kumar NP, Babu S. Impact of diabetes mellitus on immunity to latent tuberculosis infection. Front Clin Diabetes Healthc 2023;4:1095467. DOI: https://doi.org/10.3389/fcdhc.2023.1095467
Bisht MK, Dahiya P, Ghosh S, Mukhopadhyay S. The cause–effect relation of tuberculosis on incidence of diabetes mellitus. Front Cell Infect Microbiol 2023;13:1134036. DOI: https://doi.org/10.3389/fcimb.2023.1134036
Wang M, Liu Y, Liang Y, et al. Systematic understanding of pathophysiological mechanisms of oxidative stress-related conditions—diabetes mellitus, cardiovascular diseases, and ischemia–reperfusion injury. Front Cardiovasc Med 2021;8:649785. DOI: https://doi.org/10.3389/fcvm.2021.649785
Oswal N, Lizardo K, Dhanyalayam D, et al. Host metabolic changes during mycobacterium tuberculosis infection cause insulin resistance in adult mice. J Clin Med 2022;11:1646. DOI: https://doi.org/10.3390/jcm11061646
Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007;45:428-35. DOI: https://doi.org/10.1086/519841
Ngo MD, Bartlett S, Ronacher K. Diabetes-associated susceptibility to tuberculosis: contribution of hyperglycemia vs. dyslipidemia. Microorganisms 2021;9:2282. DOI: https://doi.org/10.3390/microorganisms9112282
Raguraman R, Srivastava A, Munshi A, Ramesh R. Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer. Adv Drug Deliv Rev 2021;178. DOI: https://doi.org/10.1016/j.addr.2021.113918
WHO. Global tuberculosis report 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022. Accessed on: 26/04/2025.
Wu Q, Liu Y, Ma YB, et al. Incidence and prevalence of pulmonary tuberculosis among patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Med 2022;54:1657-66. DOI: https://doi.org/10.1080/07853890.2022.2085318
Park B, Park J, Shin KM, et al. Ultrasound-guided lung biopsy for small (≤2 cm) subpleural lung lesions: comparison of diagnostic yield and safety with larger lesions. J Thorac Dis 2023;15:2485-96. DOI: https://doi.org/10.21037/jtd-22-1546
How to Cite
The effect of type 2 diabetes mellitus on clinical symptoms, sputum molecular test results, and lesions in thoracic photos of pulmonary tuberculosis patients. (2025). Italian Journal of Medicine. https://doi.org/10.4081/itjm.2025.2048
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.